These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 34366328)

  • 21.
    Shi Y; Ren X; Cao S; Chen X; Yuan B; Brasil da Costa FH; Rodriguez Rosario AE; Corona A; Michikawa C; Veeramachaneni R; Osman AA; Xie T; Wang W; Sikora AG; Myers JN; Rangel R
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37604640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
    Ogmundsdóttir HM; Björnsson J; Holbrook WP
    J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatic mutations in oral squamous cell carcinomas in 98 Japanese patients and their clinical implications.
    Osawa Y; Aoyama KI; Hosomichi K; Uchibori M; Tajima A; Kimura M; Ota Y
    Cancer Treat Res Commun; 2021; 29():100456. PubMed ID: 34563788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation profiling in the PIK3CA, TP53, and CDKN2A genes in circulating free DNA and impalpable breast lesions.
    Delmonico L; Costa MASM; Fournier MV; Romano SO; Nascimento CMD; Barbosa AS; Moreira ADS; Scherrer LR; Ornellas MHF; Alves G
    Ann Diagn Pathol; 2019 Apr; 39():30-35. PubMed ID: 30634138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Missense mutations in the TP53 DNA-binding domain predict outcomes in patients with advanced oral cavity squamous cell carcinoma.
    Lapke N; Lu YJ; Liao CT; Lee LY; Lin CY; Wang HM; Ng SH; Chen SJ; Yen TC
    Oncotarget; 2016 Jul; 7(28):44194-44210. PubMed ID: 27283772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma.
    Heaton CM; Durr ML; Tetsu O; van Zante A; Wang SJ
    Laryngoscope; 2014 Jul; 124(7):E267-73. PubMed ID: 24431303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations found in cell-free DNAs of patients with malignant lymphoma at remission can derive from clonal hematopoiesis.
    Suehara Y; Sakata-Yanagimoto M; Hattori K; Kusakabe M; Nanmoku T; Sato T; Noguchi M; Chiba S
    Cancer Sci; 2019 Oct; 110(10):3375-3381. PubMed ID: 31436356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of circulating DNA in malignant neoplasia from diverse locations: Investigating a diagnostic role.
    Kumari S; Mishra S; Husain N; Verma T; Tiwari V; Kaif M; Agarwal A; Rastogi M; Shukla S; Sonkar AA
    Indian J Pathol Microbiol; 2022; 65(1):93-99. PubMed ID: 35074971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased Plasma Circulating Cell-Free DNA Could Be a Potential Marker for Oral Cancer.
    Lin LH; Chang KW; Kao SY; Cheng HW; Liu CJ
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30352977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of Somatic Mutations with ddPCR from Liquid Biopsy of Colorectal Cancer Patients.
    Zmrzljak UP; Košir R; Krivokapić Z; Radojković D; Nikolić A
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33669856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. False-Positive Plasma Genotyping Due to Clonal Hematopoiesis.
    Hu Y; Ulrich BC; Supplee J; Kuang Y; Lizotte PH; Feeney NB; Guibert NM; Awad MM; Wong KK; Jänne PA; Paweletz CP; Oxnard GR
    Clin Cancer Res; 2018 Sep; 24(18):4437-4443. PubMed ID: 29567812
    [No Abstract]   [Full Text] [Related]  

  • 32. Epithelial-to-mesenchymal transition status correlated with ultrastructural features, and TP53 mutation in patient-derived oral cancer cell lines.
    Navarange SS; Bane SM; Mehta D; Shah S; Gupta S; Waghmare SK
    Mol Biol Rep; 2023 Oct; 50(10):8469-8481. PubMed ID: 37639153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting the DNA Damage Response in OSCC with TP53 Mutations.
    Lindemann A; Takahashi H; Patel AA; Osman AA; Myers JN
    J Dent Res; 2018 Jun; 97(6):635-644. PubMed ID: 29489434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatic mutations in tumor and plasma of locoregional recurrent and/or metastatic head and neck cancer using a next-generation sequencing panel: A preliminary study.
    Rapado-González Ó; Brea-Iglesias J; Rodríguez-Casanova A; Bao-Caamano A; López-Cedrún JL; Triana-Martínez G; Díaz-Peña R; Santos MA; López-López R; Muinelo-Romay L; Martínez-Fernández M; Díaz-Lagares Á; Suárez-Cunqueiro MM
    Cancer Med; 2023 Mar; 12(6):6615-6622. PubMed ID: 36420687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Correlation between high-risk TP53 mutation and extracapsular spread in oral squamous cell carcinoma].
    Shi L; Tao F; Liu RM; Liu QR
    Shanghai Kou Qiang Yi Xue; 2019 Dec; 28(6):644-647. PubMed ID: 32346712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TP53 mutations in circulating free DNA from Egyptian patients with non-Hodgkin's lymphoma.
    Hosny G; Farahat N; Hainaut P
    Cancer Lett; 2009 Mar; 275(2):234-9. PubMed ID: 19046801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double Drop-Off Droplet Digital PCR: A Novel, Versatile Tool for Mutation Screening and Residual Disease Monitoring in Acute Myeloid Leukemia Using Cellular or Cell-Free DNA.
    Rausch C; Rothenberg-Thurley M; Buerger SA; Tschuri S; Dufour A; Neusser M; Schneider S; Spiekermann K; Metzeler KH; Ziemann F
    J Mol Diagn; 2021 Aug; 23(8):975-985. PubMed ID: 34020042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced ratio of signals enables digital mutation scanning for rare allele detection.
    Castellanos-Rizaldos E; Paweletz C; Song C; Oxnard GR; Mamon H; Jänne PA; Makrigiorgos GM
    J Mol Diagn; 2015 May; 17(3):284-92. PubMed ID: 25772705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Automated Correction Algorithm (ALPACA) for ddPCR Data Using Adaptive Limit of Blank and Correction of False Positive Events Improves Specificity of Mutation Detection.
    Vessies DCL; Linders TC; Lanfermeijer M; Ramkisoensing KL; van der Noort V; Schouten RD; Meijer GA; van den Heuvel MM; Monkhorst K; van den Broek D
    Clin Chem; 2021 Jul; 67(7):959-967. PubMed ID: 33842952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical staining patterns of p53 predict the mutational status of TP53 in oral epithelial dysplasia.
    Sawada K; Momose S; Kawano R; Kohda M; Irié T; Mishima K; Kaneko T; Horie N; Okazaki Y; Higashi M; Tamaru JI
    Mod Pathol; 2022 Feb; 35(2):177-185. PubMed ID: 34404905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.